Skip to main content

Advertisement

Log in

Long-term treatment with arsenite activates HER1 and HER2 through upregulating EGF, TGFα, and HSP90 in a human uroepithelial cell line

  • Short Communication
  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

Download references

Funding

This work was supported by the National Natural Science Foundation of China (NSFC) (81673207 and 81373023) and the Program for Liaoning Innovative Research Team in University (LNIRT) (201610159000037).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuhua Xi.

Ethics declarations

Conflict of interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 10452 kb).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jin, P., Liu, J., Zhou, Q. et al. Long-term treatment with arsenite activates HER1 and HER2 through upregulating EGF, TGFα, and HSP90 in a human uroepithelial cell line. Cell Biol Toxicol 36, 279–284 (2020). https://doi.org/10.1007/s10565-019-09500-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10565-019-09500-9

Keywords

Navigation